	Early respon se to guselkumab and biologic-naÃ¯ve status predict sustained efficacy with extended dosing intervals in mild-to-moderate plaque psoriasis: A real-world retrospective study. J Am Acad Dermatol Park S, Oh S, Yoon HS. PMID: 41850620 [PubMed - as supplied by publisher]
	Cross-cultural adaptation and preliminary validation of the Korean version of the Psoriatic Arthritis Impact of Disease-12 questionnaire. Korean J Intern Med Koo BS, Kim JG, Yoon BY, Kang JH, Choi SE, Jung S, Kim S, Kim TJ. PMID: 41850225 [PubMed - indexed for MEDLINE]
	Associations between diet quality, genetic risk of psoriasis, and psoriasis incidence: A prospective cohort study. Clin Nutr Zhang R, Xu Y, Li B, Dregan A, Griffiths CEM, Zanesco S, Maruthappu T, Gibson R, Hall WL. PMID: 41850001 [PubMed - as supplied by publisher]
	Evaluation of serum TWEAK levels and treatment response in psoriasis and psoriatic arthritis: a prospective comparative case-control study of adalimumab and methotrexate. Clin Rheumatol Hegazy EM, Sadek EA, Ahmed SS. PMID: 41848948 [PubMed - as supplied by publisher]
	Effects of TNF-Î± Inhibitors on Subclinical Atherosclerosis and Endothelial Function in Patients with Psoriatic Arthritis: A Systematic Review. Tunis Med Makhlouf Y, Boussaa H, Bettaieb H, Fazaa A, Dergaa I, Boudokhane M, Bellakhal S, Dougui MH, Ben Abdelghan K, Miladi S, Laatar A. PMID: 41848140 [PubMed - indexed for MEDLINE]
	Adapting Glucagon-Like Peptide-1 Receptor Agonists for Innovative Psoriasis Therapy. J Cutan Med Surg Tanquilut E, Dumke M, Parga A, Suhling M, Hunt J, Bae K, Kong Y, Frasier K. PMID: 41847997 [PubMed - as supplied by publisher]
	Efficacy and Safety of Oral Icotrokinra in Moderate-to-Severe Plaque Psoriasis: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. Int J Dermatol Altayf A, Lateiresh M, Marwan L, Alfeetouri MY, Zouaoui Y, Elhadi M. PMID: 41846234 [PubMed - as supplied by publisher]
	Multiplexed serum biomarker signature integrating metallomics, Vitamin D, and MMP-9 for precision diagnosis of chronic plaque psoriasis. J Trace Elem Med Biol Abdulkarim SK, Tofiq DI, Mohammad GH. PMID: 41844456 [PubMed - as supplied by publisher]
	Association between Psoriasis Area and Severity Index Score and atherosclerotic risk in psoriasis patients using the Hisayama Score: a single-center retrospective study. Immunol Med Kobayashi A, Terui H, Shimada-Omori R, Okazaki T, Sekine M, Yano M, Takahashi T, Asano Y. PMID: 41841525 [PubMed - as supplied by publisher]
	INulin-type Î²-fructans supplementation to modulate gut microbiota and assessment of its effects on health status and GUT-SKIN axis parameters in patients with psoriasis (INGUTSKIN): the 8-week, randomised, double-blind, placebo-controlled clinical study protocol. Nutr J Krupa-Kozak U, Owczarczyk-Saczonek A, Lange E, Starowicz M, Kopcewicz M, K, Czerwi, Rybak-d'Obyrn J, Oczkowski M, De Biasi J, Bieglecka K, Kleniewska M, B, Ma, Pastuszak K. PMID: 41840402 [PubMed - as supplied by publisher]
	Complications and Laboratory Test Findings Among Patients With Generalized Pustular Psoriasis: A Retrospective Chart Review Study. Exp Dermatol Okuyama R, Okubo Y, Imafuku S, Tada Y, Yamanaka K, Sugiura K, Yamaguchi Y, Yasuda M, Sakamoto W, Saitoh M, Morita A. PMID: 41840359 [PubMed - indexed for MEDLINE]
	Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis). Dermatol Ther (Heidelb) Ibba L, Di Giulio S, Malagoli P, Balato A, Marzano AV, Megna M, Orsini D, Sacchelli L, Mercuri SR, Trovato E, Giacalone S, Pedron A, Caproni M, Cammarata E, Cuccia A, Altomare A, Brunasso AMG, Dini V, Ribero S, Zerbinati N, Messina F, Caccavale S, Carrera CG, Potestio L, Lora V, Carugno A, Bardazzi F, Paolino G, Costanzo A, Narcisi A, Valenti M. PMID: 41840326 [PubMed - as supplied by publisher]
	Immunometabolic Dysregulation in Psoriasis: Mechanisms Driving Inflammation and Emerging Therapeutic Targets. Immunol Invest Jaswal A, Kumar A, Patel P, Kurmi BD. PMID: 41839448 [PubMed - as supplied by publisher]
	Safety and Effectiveness of Nonsteroidal Tapinarof Cream 1% Added to Ongoing Biologic Therapy for Treatment of Moderate to Severe Plaque Psoriasis. Cutis Bagel J, Hetzel A, Reed A, Nelson E. PMID: 41839022 [PubMed - indexed for MEDLINE]
	Pathogenic Significance of Serum Syndecan-1 and Syndecan-4 in Psoriasis. Cutis Y, Korkmaz S, Çelik HHA, Büyükbayram H, Çelik S, Orhan H, Y, Erturan . PMID: 41839009 [PubMed - indexed for MEDLINE]
	Study protocol for a feasibility randomised controlled trial of MOVE SMART-An intervention to increase physical activity, reduce sedentary behaviour and improve health outcomes in patients with psoriasis. PLoS One Onambele-Pearson G, Ives B, Khosla I, Witkam R, Roberts M, Moorhead L, Bedson E, Cowper R, Burnside G, Young HS. PMID: 41838662 [PubMed - indexed for MEDLINE]
	Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies. Rheumatology (Oxford) Gossec L, Coates LC, Landewé RBM, Mease PJ, Merola JF, Ritchlin CT, Tanaka Y, Asahina A, Proft F, Goldammer N, Manente M, Ink B, Bajracharya R, Coarse J, McInnes IB. PMID: 41838419 [PubMed - as supplied by publisher]
	Efficacy and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis with Diabetes: Pooled Subgroup Analysis of reSURFACEÂ 1 and reSURFACEÂ 2. Dermatol Ther (Heidelb) Bagel J, Gogineni R, Shaikh A, Lebwohl MG. PMID: 41838287 [PubMed - as supplied by publisher]
	Reporting of the harms from randomized controlled trials for psoriasis: a cross-sectional meta-epidemiological study. Front Med (Lausanne) Yang Z, Xiong Y, Shen Y, Cheng Z, Dai Y, Hao P, Hu Z. PMID: 41836958 [PubMed]
	Machine learning-based prediction of PASI100 response to secukinumab in patients with psoriasis: a real-world study with SHAP interpretability analysis. Front Med (Lausanne) Hu F, Gong J, Li Y, Tao X, Zhang L. PMID: 41836943 [PubMed]

Articles 1 - 20 / 27618

Page 1 of 1381



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy